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Purpose: The individual and interaction effects of formulation variables on the release of 
suppositories were investigated using a 23 factorial experimental design. The variables 
studied were nature of base (B), type of drug (D), and presence of surfactant (S). 
Method: Suppositories were formulated with theobroma oil and Witepsol H15 as bases at 
‘low’ and ‘high’ levels respectively. Chloroquine and aminophylline, both water-soluble drugs, 
were incorporated as active constituents at ‘low’ and ‘high’ levels respectively while Tween 80 
was incorporated as surfactant in some of the formulations. Disintegration time and time 
taken for 50% of the drug to dissolve were used as assessment parameters. 
Results: The inclusion of surfactant in the suppository formulation   proved to be the most 
significant variable in the formulation. The ranking for the individual coefficient values for the 
formulations was S>>B>D for disintegration time DT and S>>>D>B for the dissolution 
parameter t50. While the ranking for the interaction effects was B-D>B-S>S-D on DT and on 
t50 S-D>B-S>B-D. 
Conclusion: The results suggest that in formulating water-soluble drugs such as chloroquine 
and aminophylline as suppositories in a hydrophobic base, the presence of a surfactant is the 
most influential variable. 
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Introduction 
The processes of release and absorption of 
drugs from suppositories are complex. The 
process of absorption has been described as 
involving three stages1: (i) destruction (i.e. 
disintegration) of the suppository, (ii) transfer 
of the drug from the excipients to the rectal 
medium i.e. drug release, and (iii) absorption 
of the drug via the rectal mucosa. Release 
and subsequent absorption depend to a 
great extent on the viscosity of the 
suppository mass and on the mechanism of 
release from fatty bases. It has been found 
reasonable1 to use a fat-like base for water-
soluble drugs. Furthermore, the diffusion rate 
of drug suspended in a fat base of both low 
hydroxyl number and viscosity is increased2.   
 
In the formulation of different drugs as 
suppositories, there is the need to determine 
the optimum formulation factors which 
depend on the drug candidate itself, 
suppository base and the presence of an 
adjuvant. It is known that the composition of 
suppository bases is an important factor in 
the release process. In addition, drug 
absorption can be modulated by the 
incorporation of absorption enhancers. The 
inclusion of these enhancers have been 
widely reported3,4 and the main 
consideration for their selection is safety, 
efficacy and compatibility with other 
formulation ingredients3. 
 
In the present work, we have carried out a 
simple quantitative assessment of how base 
type, drug type and presence or absence of 
surfactant affect the release characteristics 
of chloroquine and aminophylline 
suppositories using a three-way analysis of 
variance to determine the effects and extent 
of interactions between the three variables at 
two levels on the properties of suppositories. 
This type of analysis has been employed by 
various workers5,6,7 and has been found to 
be relevant to formulation and assessment of 
pharmaceutical systems. 
 
Chloroquine is slightly acidic in solution, 
while aminophylline is slightly alkaline. Both 
are freely water-soluble and the aim of the 
work is to obtain the best formulation for the 
drugs that would serve as a template for the 
suppository formulation of such water-
soluble drugs. 
 




These were chloroquine phospate powder 
B.P (Bayer, Germany), aminophylline 
powder B.P., Witepsol H15 (Penn 
Pharmaceuticals Ltd. U.K), theobroma oil 
B.P. (Analar Laboratory Reagents, U.K), and 
tween 80 (Raymond Lamb Chemicals, U.K). 
 
Preparation of chloroquine and 
aminophylline suppositories 
 
Chloroquine and aminophylline suppositories 
were prepared by fusion method following an 
earlier described method8,9 using theobroma 
oil and Witepsol H-15 as the suppository 
bases. Prior to incorporation, the drugs were 
passed through a 100 µm mesh sieve. Each 
batch of suppositories was prepared in metal 
moulds with six cavities. Using the 
displacement value calculation, 100 mg of 
each drug with and without absorption 
enhancer (the polyoxyethylenesorbitan fatty 
ester), Tween 80, at a concentration of 
0.5%w/v were incorporated into the 
suppositories. The suppositories were kept 
at room temperature for 24 hr after removal 
from the moulds to allow for uniform 
solidification and crystal transformation. 
 
Analysis of samples 
 
For the analysis of chloroquine samples, 
calibration curve data were generated using 
solutions of the phosphate salt in pH 7.2 
buffer solution8 in the concentration range of 
5 x 10-4 to 5 x 10-3 %w/v and absorbance 
was measured at 343 nm using UV/visible 
spectrophotometer  (Jenway 6305,  
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RealLabware Unit 33,  Watford Herts, WD1 
8SP, UK).  
 
Calibration curve data for aminophylline   
was also generated using solutions of the 
drug in the pH 7.2 buffer solution10 in the 
concentration range of 5 x 10-4 to 5 x 10-
3%w/v and absorbance was measured at 
270 nm on UV spectrophotometer. 
 
The mean drug content of each suppository 





Three variables – nature of base (B), type of 
drug (D) and concentration of surfactant (S), 
were employed at a ‘high’ level (denoted by 
the subscript H) and a ‘low’ level (subscript 
L) in a 23  , i.e. 8, factorial experimental 
design11. Using the above nomenclature, the 
eight combinations between the variables 
were: BLDLSL,  BLDHSL, BLDHSH, BLDLSH, 
BHDLSL, BHDHSL, BHDHSH, BHDLSH. 
 
BL = nature of base (theobroma oil) 
BH = nature of base (Witepsol H 15) 
DL = type of drug (chloroquine diphosphate) 
DH = type of drug (aminophylline) 
SL = nil surfactant (0% Tween 80) 
SH = presence of surfactant (0.5% Tween 80) 
 
The combinations were grouped into 
appropriate sets to enable the assessment of 
each variable on the value of disintegration 
time and dissolution time, and also to 
determine whether the variables were 
interacting or acting independently of each 
other. For example, the effect of increasing B 
from the ‘low’ level to its ‘high’ level on 
disintegration and dissolution times was 
determined by summing all the results from 
samples containing ‘high’ levels of B and 
subtracting the sums of the nature of base 
from samples containing ‘low’ levels of B. i.e. 
 
¼[(BHDLSL+BHDHSL+BHDHSH+BHDLSH) – 
(BLDLSL+BLDHSL+BLDHSH+BLDLSH)]  (1) 
The amount by which the result of this 
treatment departed from zero (irrespective of 
whether positive or negative) was a 
quantitative measure of the effect of B on 
disintegration time or dissolution times of the 
suppositories. Similar expressions were 
used for finding the effects of drug type and 
presence of surfactant. To determine 
whether there was any interaction between 
two variables, the t50 or DT values of the 
combinations in which they appeared 
together at either ‘low’ or ‘high’ levels were 
summed up and the sum of other 
combinations subtracted from the value 
obtained. For example, for B and D (B-D):- 
 
¼[(LDLSL+BLDLSH+BHDHSH+BHDHSL) – 
(BLDHSL+BLDHSH+BHDLSL+BHDLSH)]   (2) 
 
A result of zero indicates no interaction, but 
a significant departure from zero implied that 
the two variables were interacting with each 
other. Similar expressions were used for 
estimating the interactions between B and S 




The statistical significance difference in the 
drug release rate from formulations 
containing surfactant and those without 
surfactant was carried with Student t-test 
using Microsoft Excel software. At 95% 
confidence interval, 2-tailed p values less 
than or equal to 0.05 were considered 
significant. 
 
Results and Discussion 
 
The representative plot of the dissolution 
profiles of the chloroquine and aminophylline 
suppositories are given in Figure 1 and 2. 
The incorporation of Tween 80 at a 
concentration of 0.5%w/v resulted in a 
significant increase (p<0.05) in the drug 
release rate when compared with the control 
suppositories (without surfactant). Values of 
disintegration time (DT) and time for 50% 
drug release (t50) for chloroquine and 
aminophylline suppositories are presented in 
Table 1. These values were used to 
calculate the independent and interaction 
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coefficients for the variables using equations 
(1) and (2). The coefficient values are 
presented in Table 2. The individual and 
interaction effects provide a clear indication 
of the quantitative effects of the three 
variables studied on the disintegration times 
and t50 of chloroquine and aminophylline 
suppositories.  
 
In comparing the formulations, the ranking of 
the individual (independent) coefficient 
values (Table 2) for disintegration time DT, 
was S >> B > D and S >>> D > B for the 
dissolution parameter t50. The presence of 
surfactant had the highest individual effect 
on both DT and t50. This effect shows that the 
presence of a relatively small amount of 
surfactant (0.5%w/v) could lead to a 
significant change in disintegration and 
dissolution times. A similar effect was 
observed on Witepsol H 15 base through the 
use of Cremophor RH 60 at 1%w/v 
concentration13.  
 
The action of Tween 80, which is non-ionic 
surfactant, is due to the increased water 
incursion into the oily bases by decreasing 
interfacial tension. Higher concentration of 
surfactants has been observed to decrease 
drug release due to formation of water in oil 
emulsion thereby entrapping the drug 
molecules14. Abd el-Gawad et al.14 also 
found that the technique of surfactant 
incorporation could have a great role in 
enhancing drug release from suppositories. 
The effect of B on both parameters was 
negative although having a higher effect on 
disintegration time. Thus, changing the base 
from theobroma oil to Witepsol H15 led to a 
decrease in disintegration and dissolution 
times of the suppositories. This is probably 
due to the higher proportion of partial 
glycerides and hence higher hydroxyl value 
of Witepsol, making it more readily miscible 
with water than the more hydrophobic oil9.   
 
Drug type had the lowest effect on 


















Theobroma with 0.5% Tween 80
Witepsol with 0.5% Tween 80
 
Figure 1:  Dossolution profile of chloroquine 
phosphate suppositories formulated with 


















Theobroma w ith 0.5% Tw een 80
Witepsol w ith 0.5% Tw een 80
 
Figure 2:  Dossolution profile of aminophylline 
suppositories formulated with theobroma oil and 
whitesop H15 
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base type. Thus changing from chloroquine 
to aminophylline led to a decrease in 
disintegration time but increase in time for 
50% of the drug to dissolve. This effect could 
be due to particle size and particle size 
distribution of the two drugs used in this 
study. This highlights the effect of drug type 
on the release profile of different bases and 
the need to select the best base for a 
particular drug in order to ensure optimum 
release. Akala et al. found that the best base 
to ensure optimum release for amodiaquine 
hydrochloride was polyethylene glycol8. 
 
The interaction coefficients (Table 2) indicate 
the effects of the variables in combination. 
Ranking of the effects on disintegration time 
(DT) was B-D>B-S>S-D and on t50 S-D>B-
S>B-D. The interaction effects between base 
and drug types had the highest effects on 
disintegration time and lowest effect on t50. 
This effect gave a positive value indicating 
an increase in the time taken for 
disintegration and also for dissolution. 
However, B and S show a negative value of 
interaction implying a combination effect, 
which though less than the individual effect 
of the surfactant on the release, was a 
significant increase on the individual value 
of the base type effect. The magnitude of 
the interaction effects showed that there 
were generally considerable interactions 
between the presence of surfactant S and 
the other two variables D and B. This is 
probably due to the wetting effect of the 
surfactant leading to increased water 
incursion into the hydrophobic bases, 
dissolution of the drugs and consequent 




There was considerable interaction between 
the variables for the different suppository 
formulations as shown by the magnitude of 
the individual and interaction coefficient 
obtained on the disintegration and 
dissolution times. The ranking of the effect of 
individual variables were found to be S>> B> 
D and S>>> D >B for the dissolution 
parameter t50, while the   order of interactions 
found on disintegration time DT, was B-D>B-
S>S-D and on t50 S-D>B-S>B-D. The results 
suggest that in formulating a water-soluble 
drug as a suppository in a hydrophobic base, 
the presence of surfactant is the most 




Table 1: Disintegration time (min) and time for 50% 
drug dissolution t50 (min) for chloroquine and 





DT (mins) t50 (mins) 
BLDLSL  7.54 20.31 
BLDHSL 6.12 9.44 
BLDHSH 2.11 14.50 
BLDLSH 3.44 4.95 
BHDLSL 6.14 13.16 
BHDHSL 6.25 19.25 
BHDHSH 1.45 5.03 
BHDLSH 1.02 8.25 
 
BL = nature of base (theobroma oil) 
BH = nature of base (witepsol H-15) 
DL = type of drug (chloroquine diphosphate) 
DH = type of drug (aminophylline) 
SL = absence of surfactant (0% Tween 80) 
SH = presence of surfactant (0.5% Tween 80) 
Table 2: Quantitative effects of nature of base 
(B), type of drug (D) and concentration of 
surfactant (S) on disintegration time (DT) and 
t50 and of suppositories 
 
Variables    DT t50 
 
Independent Coefficient 
B -1.09 -0.88 
D -0.55  1.55 
 
S -4.51 -7.36 
Interaction Coefficient 
 B - S -0.45 -2.21 
 B - D  0.82  1.05 
 S - D  0.10  2.78 
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